Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy Ruiz

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
International Journal of Radiation Oncology, Biology, Physics|July 3, 2020
Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor TherapyCorbin A Helis, Ryan T Hughes, Chase W Glenn, et al.
Frontiers in Endocrinology|October 2, 2024
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastasesAriel R Choi, Ralph B D'Agostino, Michael K Farris, et al.
Journal of Neuro-Oncology|May 25, 2026
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patientsSarah E Glynn, Ralph D'Agostino, Claire M Lanier, et al.
Nature Biomedical Engineering|March 2, 2026
MyD88-mediated chimaeric antigen receptor macrophages suppress brain metastasis using target-specific phagocytosisShih-Ying Wu, Abhishek Tyagi, Kerui Wu, et al.
Cancers|March 28, 2025
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?Sarah E Glynn, Claire M Lanier, Ariel R Choi, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trialBaohui Han, Trevor Feinstein, Yuankai Shi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgeryEmory R McTyre, Michael H Soike, Michael Farris, et al.
Journal of Neuro-Oncology|August 23, 2017
Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogramDiandra N Ayala-Peacock, Albert Attia, Steve E Braunstein, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
International Journal of Radiation Oncology, Biology, Physics|July 3, 2020
Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor TherapyCorbin A Helis, Ryan T Hughes, Chase W Glenn, et al.
Frontiers in Endocrinology|October 2, 2024
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastasesAriel R Choi, Ralph B D'Agostino, Michael K Farris, et al.
Journal of Neuro-Oncology|May 25, 2026
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patientsSarah E Glynn, Ralph D'Agostino, Claire M Lanier, et al.
Nature Biomedical Engineering|March 2, 2026
MyD88-mediated chimaeric antigen receptor macrophages suppress brain metastasis using target-specific phagocytosisShih-Ying Wu, Abhishek Tyagi, Kerui Wu, et al.
Cancers|March 28, 2025
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?Sarah E Glynn, Claire M Lanier, Ariel R Choi, et al.
The Lancet. Respiratory Medicine|September 12, 2024
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trialBaohui Han, Trevor Feinstein, Yuankai Shi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgeryEmory R McTyre, Michael H Soike, Michael Farris, et al.
Journal of Neuro-Oncology|August 23, 2017
Prediction of new brain metastases after radiosurgery: validation and analysis of performance of a multi-institutional nomogramDiandra N Ayala-Peacock, Albert Attia, Steve E Braunstein, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Pageof 10